Published Date: 2024-03-07 21:18:53, Category: News (687512)Time: 01:25 min, View Count= 59 ( + More Social Media views ) , Rating= Title: Novo valuation beats Tesla on experimental obesity drug data | REUTERSKeywords: Novo valuation beats Tesla experimental obesity drug data | REUTERS Description: Novo Nordisk surpassed Tesla in market valuation after the maker of the popular weight-loss drug Wegovy announced positive early trial data for a highly anticipated new obesity #News #Reuters